世界の血液スクリーニング市場は、2024年に約34億米ドルと評価され、2025年から2035年にかけて11.90%という高いCAGRで拡大すると予測されています。現代の医療システムに不可欠なプロセスである血液スクリーニングは、感染性病原体の検出と輸血感染症からの患者の保護において極めて重要な役割を果たしています。献血された血液にHIV、肝炎ウイルス、梅毒などの病原体が含まれていないことを確認するための高度な検査技術が用いられます。市場の勢いは、慢性疾患、外科的介入、外傷関連処置の世界的な発生率の上昇に伴う安全な輸血への需要の高まりによって推進されています。さらに、新興国における医療インフラの拡大と、政府主導による血液検査の義務化の取り組みも、この分野の上昇傾向に拍車をかけています。
過去10年間で、血液スクリーニング技術の革新は加速し、医療提供者は検査プロトコルにおいてより高い感度と特異度を達成できるようになりました。核酸増幅検査（NAT）などの技術は、感染性病原体の診断ウィンドウを大幅に短縮し、感染リスクを最小限に抑えるという画期的な技術として登場しました。WHOのデータによると、世界的な人口の高齢化と輸血を必要とする疾患の蔓延に伴い、血液成分の需要は急増し続けています。しかし、この業界に課題がないわけではありません。高度なスクリーニング機器の高コストと厳格な規制枠組みが相まって、特にリソースが限られた環境では、迅速な導入が妨げられる可能性があります。とはいえ、自動化の統合、AI駆動型診断プラットフォーム、そして官民ヘルスケアパートナーシップの拡大により、既存企業と新規参入企業の両方に有利な機会が近づいています。
地理的視点から見ると、北アメリカは2025年に市場シェアの大部分を占めました。これは、堅固な医療制度、輸血の安全性に対する高い意識、そして最先端診断の早期導入によるものです。主要な市場プレーヤーの存在と有利な償還政策も、この地域のリーダーシップをさらに強化しています。厳格な規制、確立された血液バンク、そして高度な検査能力に支えられたヨーロッパは、これに僅差で追随しています。一方、アジア太平洋地域は、医療投資の急増、献血率の上昇、そしてインドや中国などの国々における感染症の負担増加に牽引され、予測期間中に最も高い成長を記録すると予測されています。血液安全基準の向上を目指す政府によるキャンペーンや、診断検査室の近代化への投資は、この地域の市場拡大を加速させると期待されます。ラテンアメリカと中東・アフリカも、インフラの改善と意識向上キャンペーンが定着し始めているため、緩やかなペースではあるものの、着実な成長を示しています。
本調査の目的は、近年における様々なセグメントおよび国における市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における業界の定性的および定量的側面の両方を網羅するように設計されており、市場の将来の成長を決定づける推進要因や課題といった重要な側面についても詳細な情報を提供しています。さらに、利害関係者が投資できるマイクロ市場における潜在的な機会、そして主要プレーヤーの競争環境と製品提供の詳細な分析も盛り込んでいます。
目次
Table of Contents
Chapter 1. Global Blood Screening Market Report Scope & Methodology
1.1. Research Objective
1.2. Research Methodology
1.2.1. Forecast Model
1.2.2. Desk Research
1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
1.4.1. Market Definition
1.4.2. Market Segmentation
1.5. Research Assumption
1.5.1. Inclusion & Exclusion
1.5.2. Limitations
1.5.3. Years Considered for the Study
Chapter 2. Executive Summary
2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings
Chapter 3. Global Blood Screening Market Forces Analysis
3.1. Market Forces Shaping The Global Blood Screening Market (2024-2035)
3.2. Drivers
3.2.1. Rising Demand for Safe Blood Transfusions Due to Chronic Diseases & Trauma
3.2.2. Expansion of Healthcare Infrastructure and Government Initiatives
3.3. Restraints
3.3.1. High Cost of Advanced Screening Instruments
3.3.2. Stringent Regulatory Frameworks Impacting Adoption
3.4. Opportunities
3.4.1. Integration of Automation and AI-Driven Diagnostic Platforms
3.4.2. Growth in Emerging Economies and Private-Public Healthcare Partnerships
Chapter 4. Global Blood Screening Industry Analysis
4.1. Porter’s 5 Forces Model
4.1.1. Bargaining Power of Buyer
4.1.2. Bargaining Power of Supplier
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion
Chapter 5. Global Blood Screening Market Size & Forecasts by Technology 2025-2035
5.1. Market Overview
5.2. Nucleic Acid Amplification Test (NAT)
5.2.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.2.2. Market Size Analysis, by Region, 2025-2035
5.3. ELISA
5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.3.2. Market Size Analysis, by Region, 2025-2035
5.4. Western Blotting
5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.4.2. Market Size Analysis, by Region, 2025-2035
Chapter 6. Global Blood Screening Market Size & Forecasts by Product 2025-2035
6.1. Market Overview
6.2. Reagent
6.2.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.2.2. Market Size Analysis, by Region, 2025-2035
6.3. Instrument
6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.3.2. Market Size Analysis, by Region, 2025-2035
Chapter 7. Global Blood Screening Market Size & Forecasts by Region 2025-2035
7.1. Blood Screening Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Blood Screening Market
7.3.1. U.S. Blood Screening Market
7.3.1.1. Technology Breakdown Size & Forecasts, 2025-2035
7.3.1.2. Product Breakdown Size & Forecasts, 2025-2035
7.3.2. Canada Blood Screening Market
7.3.2.1. Technology Breakdown Size & Forecasts, 2025-2035
7.3.2.2. Product Breakdown Size & Forecasts, 2025-2035
7.4. Europe Blood Screening Market
7.4.1. UK Blood Screening Market
7.4.1.1. Technology Breakdown Size & Forecasts, 2025-2035
7.4.1.2. Product Breakdown Size & Forecasts, 2025-2035
7.4.2. Germany Blood Screening Market
7.4.2.1. Technology Breakdown Size & Forecasts, 2025-2035
7.4.2.2. Product Breakdown Size & Forecasts, 2025-2035
7.4.3. France Blood Screening Market
7.4.3.1. Technology Breakdown Size & Forecasts, 2025-2035
7.4.3.2. Product Breakdown Size & Forecasts, 2025-2035
7.4.4. Spain Blood Screening Market
7.4.4.1. Technology Breakdown Size & Forecasts, 2025-2035
7.4.4.2. Product Breakdown Size & Forecasts, 2025-2035
7.4.5. Italy Blood Screening Market
7.4.5.1. Technology Breakdown Size & Forecasts, 2025-2035
7.4.5.2. Product Breakdown Size & Forecasts, 2025-2035
7.4.6. Rest of Europe Blood Screening Market
7.4.6.1. Technology Breakdown Size & Forecasts, 2025-2035
7.4.6.2. Product Breakdown Size & Forecasts, 2025-2035
7.5. Asia Pacific Blood Screening Market
7.5.1. China Blood Screening Market
7.5.1.1. Technology Breakdown Size & Forecasts, 2025-2035
7.5.1.2. Product Breakdown Size & Forecasts, 2025-2035
7.5.2. India Blood Screening Market
7.5.2.1. Technology Breakdown Size & Forecasts, 2025-2035
7.5.2.2. Product Breakdown Size & Forecasts, 2025-2035
7.5.3. Japan Blood Screening Market
7.5.3.1. Technology Breakdown Size & Forecasts, 2025-2035
7.5.3.2. Product Breakdown Size & Forecasts, 2025-2035
7.5.4. Australia Blood Screening Market
7.5.4.1. Technology Breakdown Size & Forecasts, 2025-2035
7.5.4.2. Product Breakdown Size & Forecasts, 2025-2035
7.5.5. South Korea Blood Screening Market
7.5.5.1. Technology Breakdown Size & Forecasts, 2025-2035
7.5.5.2. Product Breakdown Size & Forecasts, 2025-2035
7.5.6. Rest of APAC Blood Screening Market
7.5.6.1. Technology Breakdown Size & Forecasts, 2025-2035
7.5.6.2. Product Breakdown Size & Forecasts, 2025-2035
7.6. Latin America Blood Screening Market
7.6.1. Brazil Blood Screening Market
7.6.1.1. Technology Breakdown Size & Forecasts, 2025-2035
7.6.1.2. Product Breakdown Size & Forecasts, 2025-2035
7.6.2. Mexico Blood Screening Market
7.6.2.1. Technology Breakdown Size & Forecasts, 2025-2035
7.6.2.2. Product Breakdown Size & Forecasts, 2025-2035
7.7. Middle East and Africa Blood Screening Market
7.7.1. UAE Blood Screening Market
7.7.1.1. Technology Breakdown Size & Forecasts, 2025-2035
7.7.1.2. Product Breakdown Size & Forecasts, 2025-2035
7.7.2. Saudi Arabia (KSA) Blood Screening Market
7.7.2.1. Technology Breakdown Size & Forecasts, 2025-2035
7.7.2.2. Product Breakdown Size & Forecasts, 2025-2035
7.7.3. South Africa Blood Screening Market
7.7.3.1. Technology Breakdown Size & Forecasts, 2025-2035
7.7.3.2. Product Breakdown Size & Forecasts, 2025-2035
7.7.4. Rest of Middle East & Africa Blood Screening Market
7.7.4.1. Technology Breakdown Size & Forecasts, 2025-2035
7.7.4.2. Product Breakdown Size & Forecasts, 2025-2035
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Hoffmann-La Roche Ltd.
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Financial Performance (Subject to Data Availability)
8.2.5. Product/Services Port
8.2.6. Recent Development
8.2.7. Market Strategies
8.2.8. SWOT Analysis
8.3. Abbott Laboratories
8.4. Bio-Rad Laboratories, Inc.
8.5. Grifols, S.A.
8.6. Siemens Healthineers AG
8.7. Thermo Fisher Scientific Inc.
8.8. Ortho Clinical Diagnostics
8.9. Becton, Dickinson and Company
8.10. Beckman Coulter, Inc.
8.11. QIAGEN N.V.
8.12. Danaher Corporation
8.13. Merck KGaA
8.14. PerkinElmer Inc.
8.15. Biomerieux SA
8.16. Agilent Technologies, Inc.
List of Tables
Table 1. Global Blood Screening Market, Report Scope
Table 2. Global Blood Screening Market Estimates & Forecasts By Region 2024-2035
Table 3. Global Blood Screening Market Estimates & Forecasts By Technology 2024-2035
Table 4. Global Blood Screening Market Estimates & Forecasts By Product 2024-2035
Table 5. North America Blood Screening Market Estimates & Forecasts, 2024-2035
Table 6. U.S. Blood Screening Market Estimates & Forecasts, 2024-2035
Table 7. Canada Blood Screening Market Estimates & Forecasts, 2024-2035
Table 8. Europe Blood Screening Market Estimates & Forecasts, 2024-2035
Table 9. UK Blood Screening Market Estimates & Forecasts, 2024-2035
Table 10. Germany Blood Screening Market Estimates & Forecasts, 2024-2035
Table 11. France Blood Screening Market Estimates & Forecasts, 2024-2035
Table 12. Spain Blood Screening Market Estimates & Forecasts, 2024-2035
Table 13. Italy Blood Screening Market Estimates & Forecasts, 2024-2035
Table 14. Rest of Europe Blood Screening Market Estimates & Forecasts, 2024-2035
Table 15. Asia Pacific Blood Screening Market Estimates & Forecasts, 2024-2035
Table 16. China Blood Screening Market Estimates & Forecasts, 2024-2035
Table 17. India Blood Screening Market Estimates & Forecasts, 2024-2035
Table 18. Japan Blood Screening Market Estimates & Forecasts, 2024-2035
Table 19. Australia Blood Screening Market Estimates & Forecasts, 2024-2035
Table 20. South Korea Blood Screening Market Estimates & Forecasts, 2024-2035
Table 21. Rest of APAC Blood Screening Market Estimates & Forecasts, 2024-2035
Table 22. Latin America Blood Screening Market Estimates & Forecasts, 2024-2035
Table 23. Brazil Blood Screening Market Estimates & Forecasts, 2024-2035
Table 24. Mexico Blood Screening Market Estimates & Forecasts, 2024-2035
Table 25. Middle East & Africa Blood Screening Market Estimates & Forecasts, 2024-2035
Table 26. UAE Blood Screening Market Estimates & Forecasts, 2024-2035
Table 27. KSA Blood Screening Market Estimates & Forecasts, 2024-2035
Table 28. South Africa Blood Screening Market Estimates & Forecasts, 2024-2035
List of Figures
Figure 1. Global Blood Screening Market Revenue Growth, 2024-2035
Figure 2. Blood Screening Market Segmentation Overview
Figure 3. Research Methodology Flowchart
Figure 4. Global Blood Screening Market Drivers and Restraints
Figure 5. Porter’s Five Forces Analysis of Blood Screening Market
Figure 6. PESTEL Analysis Influencing the Blood Screening Industry
Figure 7. Market Share by Technology, 2024
Figure 8. Market Share by Product Type, 2024
Figure 9. Regional Market Share Comparison, 2024
Figure 10. North America Blood Screening Market Revenue by Country, 2024
Figure 11. Europe Blood Screening Market Revenue by Country, 2024
Figure 12. Asia Pacific Blood Screening Market Revenue by Country, 2024
Figure 13. Latin America Blood Screening Market Revenue by Country, 2024
Figure 14. Middle East & Africa Blood Screening Market Revenue by Country, 2024
Figure 15. Technology-wise Market Size Forecast, 2025-2035
Figure 16. Product-wise Market Size Forecast, 2025-2035
Figure 17. Blood Screening Market Trends and Growth Opportunities
Figure 18. Competitive Landscape and Market Positioning of Key Players
Figure 19. SWOT Analysis Framework Example (Sample Company)
Figure 20. Impact of Regulatory Policies on Market Growth
Figure 21. Innovation and Automation Adoption Trends in Blood Screening
